Sara Borhani Coca holds a Bachelor’s degree in Chemistry from the University of Girona (2021) and a Master’s degree in Pharmaceutical Chemistry from the Institut Químic de Sarrià (IQS, Barcelona, 2024), an English-taught program with intensive laboratory training focused on drug discovery and development.

Her research experience spans both academic and industrial settings. She has conducted research in supramolecular and organometallic chemistry, including the synthesis of nickel-based supramolecular nanocapsules for fullerene encapsulation within the Supramolecular Chemistry Group (QBIS-CAT) at the University of Girona, under the supervision of Dr. Xavier Ribas. In addition, her Bachelor’s thesis focused on the development of chiral organometallic ligands for cobalt(I) catalysis and was carried out during a research stay at the Casitas Lab at Philipps-Universität Marburg (Germany), under the supervision of Dr. Alicia Casitas.

She completed her Master’s thesis jointly at the Pharmaceutical Chemistry Group (IQS) and the Josep Carreras Research Institute. Her work focused on the computational design, synthesis, and biological evaluation of novel heterocyclic compounds targeting G protein-coupled receptors (GPCRs), with potential applications in leukemia treatment. This research was conducted under the supervision of Dr. Raimon Puig de la Bellacasa, Dr. Albert Gibert, and Dr. Gaël Roué.

In the industrial research environment, Sara worked as a Medicinal Chemistry Scientist Trainee in the New Chemical Entities (NCE) department at the R&D facilities of Almirall S.A., where she contributed to the synthesis and characterization of novel small-molecule candidates for dermatological indications. Following this experience, she joined the R&D department at Eurofragance S.L., where she was involved in research and development activities related to chemical innovation within the fragrance industry.

In April 2025, she was awarded a grant through the Empleo Joven de la Comunidad de Madrid program, co-financed by the European Social Fund Plus (ESF+). She subsequently joined the Medicinal Chemistry Laboratory at the Complutense University of Madrid to pursue her doctoral research, focused on the development of chemical probes for the identification of molecular targets of cannabidiol (CBD), under the supervision of Dr. Henar Vázquez and Dr. Silvia Ortega.